Méhtestrák: vizsgálatok itt: Kína
86 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in KínaTR115 in ARID1A-Mutated Advanced Solid Tumors
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 50
- Run by
- Tarapeutics Science Inc.
See details and how to joinNCT07793318 - 1/2. fázisTaking peopleA Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
- Where
- Anyang, Baoding, Beijing, Bengbu, Changchun, Changsha, Changzhou, Chongqing, Guangzhou, Hangzhou, Hefei, Hongcun, Jinan, Jining, Kunming, Lanzhou, Liaocheng, Nanchang, Nanning, Shanghai, Shenyang, Tianjin, Wenzhou, Wuhan, Wuxi, Xiamen, Xi’an, Xuzhou, Yantai, Yulin, Zhengzhou, Zibo
- Életkor
- 18 év and over
- People
- 796 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05150691 - 2. fázisNot yet taking people in KínaMazdutide Plus LNG-IUS for Fertility-Sparing Treatment of AEH or Early Endometrial Cancer
- Where
- Changchun, Hangzhou, Shanghai, Tianjin, Wuhan, Zhengzhou
- Életkor
- 18 év to 45 év
- People
- 128
- Run by
- Tongji Hospital
See details and how to joinNCT07781150 - No phaseTaking peopleFertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer
- Where
- Beijing
- Életkor
- Up to 45 év
- People
- 16
- Run by
- Peking University People's Hospital
See details and how to joinNCT06468215 - 1. fázisTaking peopleA First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
- Where
- Jinan
- Életkor
- 18 év to 75 év
- People
- 299 worldwide
- Run by
- Huahui Health
See details and how to joinNCT07623369 - No phaseTaking peoplePD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer
- Where
- Beijing
- Életkor
- 18 év to 45 év
- People
- 10
- Run by
- Peking University People's Hospital
See details and how to joinNCT06549855 - 2. fázisNot yet taking people in KínaElemene Liposomes in Endometrial Cancer
- Where
- Hangzhou
- Életkor
- 18 év to 80 év
- People
- 212
- Run by
- Women's Hospital School Of Medicine Zhejiang University
See details and how to joinNCT07738315 - 2. fázisTaking peopleClinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 39
- Run by
- Women's Hospital School Of Medicine Zhejiang University
See details and how to joinNCT06561308 - 3. fázisTaking peoplePuxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Where
- Beijing, Changchun, Changsha, Chengdu, Chongqing, Dalian, Fuzhou, Guangzhou, Hangzhou, Jinan, Nanchang, Nanjing, Shanghai, Shenyang, Shenzhen, Shijiazhuang, Tianjin, Wenzhou, Wuhan, Xi'an, Zhanjiang, Zhengzhou
- Életkor
- 18 év and over
- People
- 800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07044336 · EU 2024-518777-34-00 - 1. fázisTaking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- Beijing, Shanghai
- Életkor
- 18 év and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00 - 2. fázisNot yet taking people in KínaOrlistat Plus Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical Hyperplasia
- Where
- Beijing
- Életkor
- Up to 46 év
- People
- 48
- Run by
- Peking University People's Hospital
See details and how to joinNCT07714070 - 1/2. fázisTaking peopleA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 178
- Run by
- Shenzhen Ionova Life Sciences Co., Ltd.
See details and how to joinNCT07610798 - 2. fázisTaking peopleTQB2450 Plus Progestin for Fertility-sparing Treatment in MMRd EC
- Where
- Shanghai
- Életkor
- 18 év to 45 év
- People
- 10
- Run by
- Fudan University
See details and how to joinNCT06914297 - 2/3. fázisTaking peopleTrop2-targeted immunoPET Imaging of Solid Tumors
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 400
- Run by
- RenJi Hospital
See details and how to joinNCT06851663 - 1/2. fázisTaking peopleA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic Solid Tumor
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 201
- Run by
- Shenzhen Ionova Life Sciences Co., Ltd.
See details and how to joinNCT07612891 - No phaseTaking people18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 200
- Run by
- Peking University First Hospital
See details and how to joinNCT07557225 - 2. fázisTaking peopleRomiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 220
- Run by
- Peking University People's Hospital
See details and how to joinNCT07586826 - 2. fázisTaking peopleCadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma
- Where
- Jinan
- Életkor
- 18 év to 80 év
- People
- 30
- Run by
- Shandong Cancer Hospital and Institute
See details and how to joinNCT06532539 - 2. fázisTaking peopleIntrauterine Injection of Type III Collage in FST of EC/AEH
- Where
- Beijing
- Életkor
- 18 év to 45 év
- People
- 30
- Run by
- Wang Jianliu
See details and how to joinNCT07377734 - 2. fázisTaking peopleStudy of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer
- Where
- Beijing, Changsha, Chongqing, Fuzhou, Ganzhou, Guangzhou, Hangzhou, Jinan, Linyi, Nanjing, Shanghai, Shenyang, Tai’an, Tianjing, Wuhan, Yueyang, Zhengzhou
- Életkor
- 18 év and over
- People
- 108
- Run by
- 3D Medicines (Sichuan) Co., Ltd.
See details and how to joinNCT05112991 - 2/3. fázisNot yet taking people in KínaRefining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification
- Where
- Shanghai
- Életkor
- 18 év to 45 év
- People
- 260
- Run by
- Fudan University
See details and how to joinNCT07319429 - 1/2. fázisTaking peopleAn Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors
- Where
- Beijing, Hangzhou, Zhengzhou
- Életkor
- 18 év and over
- People
- 266
- Run by
- Beijing Tide Pharmaceutical Co., Ltd
See details and how to joinNCT07371663 - 2. fázisTaking peopleA Study of BL-B01D1 + Pembrolizumab ± Bevacizumab in Patients With Recurrent or Metastatic Cervical Cancer and Endometrial Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 96
- Run by
- Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT07054567 - 1. fázisTaking peopleThe Safety, Tolerability, and Efficacy of KD01 in Gynecologic Malignancies
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 97
- Run by
- Tongji Hospital
See details and how to joinNCT06552598 - 1. fázisTaking peopleA Study of BL0175 Injection in Postmenopausal Female Adults With HR-positive, Locally Advanced or Metastatic Cancer
- Where
- Changchun, Jinan
- Életkor
- 18 év and over
- People
- 9
- Run by
- Shanghai Best-Link Bioscience, LLC
See details and how to joinNCT06738966